0000905148-24-001566.txt : 20240521
0000905148-24-001566.hdr.sgml : 20240521
20240521160432
ACCESSION NUMBER: 0000905148-24-001566
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240517
FILED AS OF DATE: 20240521
DATE AS OF CHANGE: 20240521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Devroe Eric
CENTRAL INDEX KEY: 0001950573
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41551
FILM NUMBER: 24969291
MAIL ADDRESS:
STREET 1: C/O ACRIVON THERAPEUTICS, INC.
STREET 2: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acrivon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781174
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 825125532
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-207-8979
MAIL ADDRESS:
STREET 1: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
form4.xml
X0508
4
2024-05-17
0001781174
Acrivon Therapeutics, Inc.
ACRV
0001950573
Devroe Eric
C/O ACRIVON THERAPEUTICS, INC.
480 ARSENAL WAY, SUITE 100
WATERTOWN
MA
02472
true
Chief Operating Officer
false
Common Stock
2024-05-17
4
M
0
10000
1.04
A
69097
D
Stock Option (Right to Buy)
1.04
2024-05-17
4
M
0
10000
0
D
2031-01-13
Common Stock
10000
86615
D
Twenty-five percent (25%) of the shares subject to the option vested on October 5, 2021, and the remaining shares subject to the option vested or shall vest in 12 equal quarterly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
2024-05-21